Home
Explore NIH Technologies
Explore work by over 1,500 NIH researchers | Available for Licensing & Collaboration
Technologies
markup goes hereAvailable Technologies
Explore Featured Research
Get updates on the latest and most exciting research coming out of NIH...
Explore Featured Products
Novel and interesting products coming to market through NIH inventions and partnerships...
News
Start 2022 off organized by receiving a free copy of the Federal Laboratory Consortium’s (FLC) 2022 planner! Each year the FLC collects photos from the labs that are a member and selects the best ones to make an eye-catching planner. It features a variety of images showcasing innovative research and
The National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are seeking licensees for a personalized tumor vaccine for cancer immunotherapy. Immunologically “cold” tumors have low T-cell infiltration whereas immunologically “hot
Register today for NCI’s webinar on an available COVID-19 vaccine that recently completed a study demonstrating how the vaccine prevented SARS-CoV-2 transmission and infection. Current SARS-CoV-2 vaccines utilize an intramuscular injection, while this technology combines an intramuscular injection
The National Cancer Institute (NCI) is seeking a collaboration partner for a COVID-19 therapeutic that will stop the infected cells from replicating inside a host. When SARS-CoV-2 enters a host, the cells replicate it and viral particles invade the nearby healthy cells. This happens because SARS-CoV